We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BGI Expands its Shenzhen and Hong Kong Branches with Addition of 12 Illumina Genome Analyzers
News

BGI Expands its Shenzhen and Hong Kong Branches with Addition of 12 Illumina Genome Analyzers

BGI Expands its Shenzhen and Hong Kong Branches with Addition of 12 Illumina Genome Analyzers
News

BGI Expands its Shenzhen and Hong Kong Branches with Addition of 12 Illumina Genome Analyzers

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BGI Expands its Shenzhen and Hong Kong Branches with Addition of 12 Illumina Genome Analyzers"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Illumina, Inc. has announced that BGI purchased 12 additional Genome Analyzers, expanding their installed base of Illumina’s next-generation sequencing platforms to 29 units. Of the new units, four will be installed at BGI, Shenzhen and eight will be installed at BGI, Hong Kong.

This added capacity will help researchers at BGI expedite efforts around key programs such as the 1000 Genomes Project, the Chinese Cancer Genome project, the Tree of Life project, and other initiatives that accelerate BGI’s work in agriculture, human health, and biofuels.

“Purchasing 12 Genome Analyzers from Illumina is the first step in a multi-phase scale-up effort we plan to carry out in the near future. And with the opening of our new research facility in Hong Kong we wanted to arm our team of scientists with what we believe is the best in class sequencing technology,” said Xiuqing Zhang, Ph.D., Director of Sequencing Division at BGI.
Advertisement